Private equity firms in the Asia-Pacific region are increasingly targeting advanced manufacturing and healthcare companies with steadier cash flows, a shift driven by global uncertainty and a downturn in fundraising that has dropped to a 12-year low, according to Bain & Co research.
What Happened
Research from Bain & Co shows that investors focused on the Asia-Pacific private equity market are reallocating capital away from the once-dominant technology, media and telecommunications (TMT) sector toward businesses that produce more predictable revenue. The move is reflected in growing interest in advanced manufacturing and healthcare—areas where cash-flow visibility is typically stronger.
Elsa Sit, practice vice-president in Bain’s Asia-Pacific private equity team, described the trend as “a gradual move, driven by the external environment and uncertainties.” The shift comes as fundraising activity for the region has slowed markedly, with Bain reporting that capital raising has fallen to its lowest point in 12 years.
Background
The private equity landscape in Asia-Pacific expanded rapidly over the past decade as technology and consumer-facing sectors attracted large allocations of global capital. More recently, however, that trend has moderated. Investors are reassessing risk-return profiles amid an uncertain macroeconomic environment, and many are prioritizing targets that can deliver stable operating cash flow and resilience to volatility.
Advanced manufacturing companies often offer tangible assets, supply-chain linkage and steady post-sale service revenues. Healthcare businesses can provide recurring income through established patient flows, long product lifecycles and, in some cases, regulated pricing structures. Those characteristics make them comparatively attractive when investors are focused on preserving capital and ensuring predictable returns.
Why It Matters
The reorientation of private equity capital in Asia-Pacific has implications for companies seeking investment and for the broader regional economy. For fund managers, moving to sectors with clearer cash conversion can reduce exposure to valuation swings in more volatile industries. For portfolio companies, it may mean greater scrutiny on operational performance and cash management rather than on rapid top-line growth.
For markets and dealmakers in Latin America and Panama that compete for international private equity, the change in investor preferences could influence the types of deals that attract cross-border capital. Firms in advanced manufacturing and healthcare sectors might find strengthened interest from Asia-focused funds searching for predictable returns, while technology and media businesses could face tighter capital conditions from this pool of investors.
Finally, a prolonged reduction in fundraising—reaching a 12-year low—could constrain the pace of buyouts, growth investments and exits across the region. Slower fund flows typically lead investors to be more selective, extend holding periods for existing portfolio companies and place greater emphasis on operational improvements that generate cash.
As private equity players adapt their strategies, companies and advisers across Asia-Pacific (and those abroad that rely on capital from the region) will need to align their business models and pitch materials to show the cash-flow strengths that investors are now prioritizing.